Kommentar
Revisiting TNM staging for EBV-related nasopharyngeal carcinoma
Cancer Cell · 2024
DOI: 10.1016/j.ccell.2024.01.014 ↗Kurz gefasst
Kommentar in der Zeitschrift Cancer Cell, 2024. Verfasst von Michael Dennis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Center for Head & Neck Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Hauptthemen laut MEDLINE: Carcinoma, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
CarcinomaNasopharyngeal NeoplasmsHumansNeoplasm StagingNasopharyngeal CarcinomaHerpesvirus 4, HumanPrognosisRetrospective Studies
Autor:innen und Institutionen
- Department of Medical Oncology, Center for Head & Neck Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
- Department of Medical Oncology, Center for Head & Neck Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address: robert_haddad@dfci.harvard.edu.
Zitieren
APA
Dennis, M., & Haddad, R. (2024). Revisiting TNM staging for EBV-related nasopharyngeal carcinoma. Cancer Cell. https://doi.org/10.1016/j.ccell.2024.01.014
Vancouver
Dennis M, Haddad R. Revisiting TNM staging for EBV-related nasopharyngeal carcinoma. Cancer Cell. 2024. doi:10.1016/j.ccell.2024.01.014
BibTeX
@article{Dennis2024,
author = {Dennis, Michael and Haddad, Robert},
title = {Revisiting TNM staging for EBV-related nasopharyngeal carcinoma},
journal = {Cancer Cell},
year = {2024},
doi = {10.1016/j.ccell.2024.01.014}
}
EUVIMED